CCCC
Price
$2.54
Change
-$0.04 (-1.55%)
Updated
Dec 11 closing price
Capitalization
246.16M
69 days until earnings call
Intraday BUY SELL Signals
SVRA
Price
$6.94
Change
+$0.25 (+3.74%)
Updated
Dec 11 closing price
Capitalization
1.41B
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CCCC vs SVRA

Header iconCCCC vs SVRA Comparison
Open Charts CCCC vs SVRABanner chart's image
C4 Therapeutics
Price$2.54
Change-$0.04 (-1.55%)
Volume$922.96K
Capitalization246.16M
Savara
Price$6.94
Change+$0.25 (+3.74%)
Volume$2.97M
Capitalization1.41B
CCCC vs SVRA Comparison Chart in %
CCCC
Daily Signal:
Gain/Loss:
SVRA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CCCC vs. SVRA commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and SVRA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (CCCC: $2.54 vs. SVRA: $6.94)
Brand notoriety: CCCC and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 50% vs. SVRA: 130%
Market capitalization -- CCCC: $246.16M vs. SVRA: $1.41B
CCCC [@Biotechnology] is valued at $246.16M. SVRA’s [@Biotechnology] market capitalization is $1.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileSVRA’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • SVRA’s FA Score: 1 green, 4 red.
According to our system of comparison, both CCCC and SVRA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while SVRA’s TA Score has 4 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 5 bearish.
  • SVRA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SVRA is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а -1.93% price change this week, while SVRA (@Biotechnology) price change was +8.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

CCCC is expected to report earnings on Feb 19, 2026.

SVRA is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SVRA($1.41B) has a higher market cap than CCCC($246M). SVRA YTD gains are higher at: 126.059 vs. CCCC (-29.444). CCCC has higher annual earnings (EBITDA): -109.63M vs. SVRA (-116.49M). CCCC has more cash in the bank: 215M vs. SVRA (146M). SVRA has less debt than CCCC: SVRA (29.7M) vs CCCC (62.9M). CCCC has higher revenues than SVRA: CCCC (34.2M) vs SVRA (0).
CCCCSVRACCCC / SVRA
Capitalization246M1.41B17%
EBITDA-109.63M-116.49M94%
Gain YTD-29.444126.059-23%
P/E RatioN/AN/A-
Revenue34.2M0-
Total Cash215M146M147%
Total Debt62.9M29.7M212%
FUNDAMENTALS RATINGS
SVRA: Fundamental Ratings
SVRA
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
31
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCSVRA
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 15 days ago
83%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signal:
Gain/Loss:
SVRA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEQAX18.000.22
+1.24%
ICON Equity Income Investor
VSEQX42.640.38
+0.90%
Vanguard Strategic Equity Inv
NWALX39.140.35
+0.90%
Nationwide BNY Mellon Dyn US Eq Inc A
MAICX10.710.03
+0.28%
Victory Trivalent Intl Fd-Core Eq A
RDWBX13.730.02
+0.15%
American Funds Dvlpg Wld Gr&Inc R2

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-1.55%
BEAM - CCCC
42%
Loosely correlated
+0.40%
PYXS - CCCC
41%
Loosely correlated
+2.80%
AXON - CCCC
40%
Loosely correlated
+2.22%
ALGS - CCCC
40%
Loosely correlated
+1.59%
GLUE - CCCC
40%
Loosely correlated
-3.89%
More

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with RCKT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
+3.74%
RCKT - SVRA
59%
Loosely correlated
-4.96%
PRTA - SVRA
45%
Loosely correlated
+4.66%
OCUL - SVRA
37%
Loosely correlated
-4.80%
RGNX - SVRA
37%
Loosely correlated
-1.61%
VYGR - SVRA
36%
Loosely correlated
-0.23%
More